Becker A - Search Results

1

Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosis.

Eisenacher S, Rausch F, Ainser F, Englisch S, Becker A, Mier D, Fenske S, Meyer-Lindenberg A, Kirsch P, Zink M. Eisenacher S, et al. Among authors: becker a. Early Interv Psychiatry. 2018 Aug;12(4):586-595. doi: 10.1111/eip.12350. Epub 2016 May 12. Early Interv Psychiatry. 2018. PMID: 27169782

2

Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial.

Schneider BC, Brüne M, Bohn F, Veckenstedt R, Kolbeck K, Krieger E, Becker A, Drommelschmidt KA, Englisch S, Eisenacher S, Lee-Grimm SI, Nagel M, Zink M, Moritz S. Schneider BC, et al. Among authors: becker a. BMC Psychiatry. 2016 Feb 27;16:51. doi: 10.1186/s12888-016-0756-2. BMC Psychiatry. 2016. PMID: 26921116 Free PMC article. Clinical Trial.

3

Bias against disconfirmatory evidence in the 'at-risk mental state' and during psychosis.

Eisenacher S, Rausch F, Mier D, Fenske S, Veckenstedt R, Englisch S, Becker A, Andreou C, Moritz S, Meyer-Lindenberg A, Kirsch P, Zink M. Eisenacher S, et al. Among authors: becker a. Psychiatry Res. 2016 Apr 30;238:242-250. doi: 10.1016/j.psychres.2016.02.028. Epub 2016 Feb 17. Psychiatry Res. 2016. PMID: 27086240

4

Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept Study.

Englisch S, Jung HS, Lewien A, Becker A, Nowak U, Braun H, Thiem J, Eisenacher S, Meyer-Lindenberg A, Zink M. Englisch S, et al. Among authors: becker a. J Clin Psychopharmacol. 2016 Dec;36(6):597-607. doi: 10.1097/JCP.0000000000000587. J Clin Psychopharmacol. 2016. PMID: 27805978 Clinical Trial.

5

Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression: Results From the AGOPSYCH Study.

Englisch S, Jung HS, Eisenacher S, Lewien A, Becker A, Nowak U, Braun H, Thiem J, Meyer-Lindenberg A, Zink M. Englisch S, et al. Among authors: becker a. J Clin Psychopharmacol. 2018 Aug;38(4):357-361. doi: 10.1097/JCP.0000000000000909. J Clin Psychopharmacol. 2018. PMID: 29912792

6

Response to Agomelatine Treatment is Independent of Smoking Status and Dosage: Results From the AGOPSYCH Study.

Englisch S, Jung HS, Lewien A, Becker A, Nowak U, Braun H, Eisenacher S, Thiem J, Meyer-Lindenberg A, Zink M. Englisch S, et al. Among authors: becker a. Pharmacopsychiatry. 2019 Mar;52(3):142-146. doi: 10.1055/a-0606-5240. Epub 2018 May 7. Pharmacopsychiatry. 2019. PMID: 29734455

7

Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial.

Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Verde PE, Correll CU, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl TB, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Leucht S, Cordes J; COMBINE Study Group. Schmidt-Kraepelin C, et al. Lancet Psychiatry. 2022 Apr;9(4):291-306. doi: 10.1016/S2215-0366(22)00032-3. Epub 2022 Mar 8. Lancet Psychiatry. 2022. PMID: 35276079 Clinical Trial.

8

Central nervous system processing of emotions in children with faecal incontinence.

Becker A, Rubly M, El Khatib D, Becker N, von Gontard A. Becker A, et al. Among authors: becker n. Acta Paediatr. 2011 Dec;100(12):e267-74. doi: 10.1111/j.1651-2227.2011.02348.x. Epub 2011 Jun 11. Acta Paediatr. 2011. PMID: 21557764

9

Central nervous system processing of emotions in children with nocturnal enuresis and attention-deficit/hyperactivity disorder.

Equit M, Becker A, El Khatib D, Rubly M, Becker N, von Gontard A. Equit M, et al. Among authors: becker a, becker n. Acta Paediatr. 2014 Aug;103(8):868-78. doi: 10.1111/apa.12676. Epub 2014 May 30. Acta Paediatr. 2014. PMID: 24799133

10

Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity.

Meeus F, Funeh CN, Awad RM, Zeven K, Autaers D, De Becker A, Van Riet I, Goyvaerts C, Tuyaerts S, Neyns B, Devoogdt N, De Vlaeminck Y, Breckpot K. Meeus F, et al. Among authors: de becker a. J Immunother Cancer. 2024 Nov 19;12(11):e009110. doi: 10.1136/jitc-2024-009110. J Immunother Cancer. 2024. PMID: 39562005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,082 results

Search Page

Filters